Case Discussion: Systemic Therapy for Metastatic Renal Cell Carcinoma.
First-line systemic therapy for patients with metastatic renal cell carcinoma should largely entail the use of targeted agents. Depending on the clinical factors, VEGF- or mTOR-directed agents may be appropriate.